End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
55 ZAR | -1.26% | +2.14% | -8.49% |
02-21 | Adcock Ingram Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
02-21 | Transcript : Adcock Ingram Holdings Limited, H1 2024 Earnings Call, Feb 21, 2024 |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- With regards to fundamentals, the enterprise value to sales ratio is at 0.89 for the current period. Therefore, the company is undervalued.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-8.49% | 440M | B | ||
+20.45% | 43.39B | B- | ||
+19.44% | 22.01B | B+ | ||
+18.44% | 15.46B | - | ||
+25.55% | 14.93B | B+ | ||
+60.87% | 13.13B | B | ||
-0.05% | 6.79B | - | - | |
-15.02% | 6.36B | B+ | ||
-8.87% | 5.73B | - | - | |
+10.57% | 5.43B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- AIP Stock
- Ratings Adcock Ingram Holdings Limited